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Abstract - Cervical and breast cancers are the two top leading cases of female cancer worldwide. Both cases’ regiments 
usually involve chemotherapy to some extends. One of the side effects of chemotherapy usage in cancer management is the 
occurrence of cancer-related fatigue (CRF) resulted in impaired quality of life. This study aimed to analyze the effect of 
chemotherapy on CRF in cervical and breast cancer survivors. This cross-sectional study involved 41 and 26 cervical and 
breast cancer survivors respectively, in the district of Rangkah, Gading, and Pacarkeling, Surabaya, Indonesia. Instrument of 
Fatigue Symptom Inventory (FSI) was used in data collection. Independent sample T test, Mann-Whitney U test, and linear 
regression test were used in data analysis (α<.05). Results showed that most respondents undertook chemotherapy only or in 
combination with surgery and radiotherapy (@32.8%). As a side effect, most respondents experienced mild fatigue (64.2%). 
Regiment for both cases was not significantly different (p=.076), but CRF level between both cases was significantly different 
(p=.009). Chemotherapy has no significant effect on CRF both in cervical and breast cancer survivors (p=.060 and p=.784 
respectively). Other potential factors possibly play a more important role in determining CRF level in both cases, such as 
cancer symptom, malnutrition, infection, comorbidity, psychological and emotional distress.  
 
Index Terms - Breast cancer, cervical cancer, chemotherapy, cancer-related fatigue.  
 
I. INTRODUCTION 
 
Cancer is the growth of new cells that form abnormal 
tissue and characterized by uncontrolled function 
[11]. A study in 187 countries from 1980 until 2010 
was conducted to analyze the epidemic of cervical and 
breast cancer incidence and mortality worldwide. 
Global breast cancer incidence increased from 
641,000 (95% uncertainty intervals 
610,000–750,000) cases in 1980 to 1,643,000 
(1,421,000–1,782,000) cases in 2010, an annual rate 
of increase of 3.1%. Global cervical cancer incidence 
increased from 378,000 (256,000–489,000) cases per 
year in 1980 to 454,000 (318,000–620,000) cases per 
year in 2010—a 0.6% annual rate of increase. Breast 
cancer killed 425 000 (359,000–453,000) women in 
2010, of whom 68,000 (62,000–74,000) were aged 
15–49 years in developing countries. Cervical cancer 
death rates have been decreasing but the disease still 
killed 200,000 (139,000–276,000) women in 2010, of 
whom 46,000 (33,000–64,000) were aged 15–49 years 
in developing countries. More policy attention is 
needed to strengthen established health system 
responses to reduce breast and cervical cancer, 
especially in developing countries [6] In 2008, 
Indonesia's death rate from cancer was 245 per 
100,000 inhabitants (men > women); in which lung 
cancer being the most frequent killer, followed by 
breast and colon cancer (WHO, 2008) [22]. It can be 
estimated that the incidence of cancer in Indonesia is 
0.1% of the population, and more than 50% of cancer 
patients firstly come to seek for medication in an 
advanced stage [22]. In 2014, the incidence of breast 
cancer occupies the first position, followed by cervical 
cancer with the number of 20,928 cases in Indonesia 
[26]. In the period of six years we can see that more 
women suffered from cancer in Indonesia. 
In general, cancer therapy includes surgery, 
chemotherapy and radiotherapy. Chemotherapy is a 
therapy that involves the use of chemicals or drugs 
that aim to kill cancer cells [15]. The hybrid model 
suggests that cancer-related stressors and cancer 
therapies cause a decrease in four major areas, such as 
cognitive function, nutrition, muscle strength, and 
sleep quality, affecting the ability to adapt to ill 
conditions; where changes in the biological, 
psychological, and functional aspects result in CRF 
[14]. The negative impact of CRF can even be felt 
before the formal diagnosis of cancer established, and 
continues to be experienced during the treatment 
process. CRF has significant impact on health status 
[1]. CRF is subjective, which can affect physical and 
cognitive function, psychosocial, and can reduce QOL 
[10]. The National Comprehensive Cancer Network 
(2015) defines CRF as a distressing, persistent, 
subjective sense of physical, emotional, and/or 
cognitive tiredness or exhaustion related to cancer or 
cancer treatment that is not proportional to recent 
activity and interferes with usual functioning [23]. 
Although subjective CRF is often related to objective 
changes in physical functioning or impaired 
performance status, the two phenomena are not 
synonymous and need to be distinguished. The 
underlying mechanisms and pathophysiology of CRF 
are unclear [19]. Pathobiology of CRF is very 
complicated, and is caused by a cascade of events that 
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result in the production of proinflammatory cytokines, 
HPA activation dysfunction, endocrine and/or 
metabolic dysregulation, circadian rhythm disorders, 
and neuromuscular function abnormalities [17].  
CRF is a symptom that is often experienced by the 
majority of cancer patients, especially those who 
undergoing chemotherapy or radiation therapy [4]. 
Oppositely, Jean-Pierre, et al. (2007) stated that CRF 
is not affected by the type of cancer, nor the type of 
therapy that is undertaken [10]. There is still a debate 
in the fields about whether the use of chemotherapy 
causes fatigue/CRF in cancer patients or not. This 
study aimed to analyze the effect of chemotherapy on 
CRF, especially in cervical and breast cancer 
survivors.  
 
II. METHOD 
 
A. Design and Ethic 
This is a cross-sectional study in which no follow-up 
was conducted. Data were obtained at one time. Prior 
to study, the protocol has been reviewed by the ethical 
committee of Faculty of Nursing, Universitas 
Airlangga, Surabaya, Indonesia (ethical clearance 
certificate number: 681-KEPK). 
 
B. Sample 
Population was all cervical and breast cancer 
survivors in the district of Rangkah, Gading, and 
Pacar Keling, Surabaya (N=105). Inclusion criteria 
was adult (> 18 years old), cancer diagnosis has been 
confirmed by authorized health center, chemotherapy 
was being one of the regiment, and regularly 
home-visited by a palliative volunteer under the 
supervision of Rangkah Public Health Center, 
Surabaya, Indonesia. Exclusion criteria were bad 
physical/psychological condition, disorientation, 
impaired consciousness, and rejection on filling out 
the consent form. Total sampling was applied and 
sample size of 67 was obtained: 41 and 26 cervical and 
breast cancer survivors respectively.  
 
C. Instrument 
Questionnaire of demography (self-developed) and 
Fatigue Symptom Inventory (FSI) developed by 
Moffitt Cancer Center and University of South Florida 
(1998) were used for collecting data [9]. Therapy or 
regiment was coded into six categories: 1 = 
chemotherapy only, 2 = surgery + chemotherapy, 3 = 
chemoradiotherapy, 4 = surgery + chemoradiotherapy, 
5 = surgery + chemoradiotherapy + analgesic, and 6 = 
surgery + chemoradiotherapy + oral medicine (other 
than analgesic). FSI consists of four domains spread in 
14 items of fatigue self-assessment: severity (4 items), 
frequency (2 items), diurnal variation (1 item), and 
impact on quality of life (7 items). Total score of FSI 
was categorized into three levels of CRF: mild, 
moderate, and severe CRF by total score of 0-44, 
45-88, and 89-134 respectively. Data were then 
analyzed by independent sample T test, 
Mann-Whitney U test, and linear regression test 
(α<.05). 
III. RESULTS  
 
There were 41 and 26 cervical and breast cancer 
survivors participated in this study. Table 1 explains 
the demographic characteristics of study respondents. 
Most respondents are married woman, 51-60 years 
old, housewife, Islam, Javanese, high school 
graduates, lives with spouse, and Gross Domestic 
Product (GDP) less than minimum wage of Surabaya 
in 2018 (IDR 3.2 million). These results indicate that 
majority of cervical/breast cancer suffered by late 
adult women with lower middle socioeconomic status. 
Table 2 explains primary data related to cancer 
diagnosis and regiments/treatment. Most respondents 
were diagnosed with cancer before 2014. This fact 
indicated that the survival rate of both cases is 
particularly long, which makes them a chronic disease 
with high burden and requires long-term supportive 
care. Table 3 explains the CRF level in both cases. 
Most respondents experienced mild fatigue (64.2%). 
Result of Mann-Whitney U test showed that therapy of 
cervical and breast cancers was not significantly 
different (p=.076), but result of independent T test 
showed that CRF level was significantly different 
between survivors of cervical and breast cancers 
(p=.009) especially in item 11 and 13 of FSI about 
CRF-induced mood disorder and frequency of CRF 
occurrence per day respectively (p=.025 and p=.011 
respectively). There was a big possibility that CRF in 
both cases was not induced by chemotherapy. Result of 
linear regression test confirmed that overall therapy 
was not significantly influenced CRF in cervical and 
breast cancer survivors (p=.432). Specific linear 
regression in each case showed that chemotherapy has 
no significant effect on CRF with p=.060 and p=.784 
for cervical and breast cancer respectively. 
 
IV. DISCUSSION 
 
Results showed that chemotherapy has no significant 
effect on CRF, both in cervical and breast cancer 
survivors. This fact was obtained potentially because 
the therapy of both cases was not significantly 
different, but CRF level was found to be significantly 
different between cases. This study result was 
supported by Jean-Pierre et al. (2007) who stated that 
CRF is not affected by the type of cancer, nor the type 
of therapy that is undertaken [10]. Minton, et al. 
(2012) also found that there was no correlation 
between demographic characteristic and therapy with 
CRF [13]. Generally, therapy of cancer includes 
surgery, chemotherapy, and radiotherapy. In early 
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stage, surgery is highly recommended than other types 
of therapy, but oppositely for the advanced stage. 
Surgery in advanced stage was done for palliative 
purposes: increasing quality of life by alleviating 
disturbing symptoms and increasing life functioning. 
The usage of chemotherapy in advanced stage was 
preferred because of its systemic effect, compare to the 
local effect of surgery and radiotherapy. But, its usage 
also induced many side effects, such as severe nausea 
and vomiting resulted in malnutrition, hair loss 
(alopecia) and darken/dry skin resulted in impaired 
body image, increases of pain intensity and risk of 
infection, diarrhea, stomatitis, neuropathy, myalgia, 
tasting change, and trombositopenia [15]. 
 
 
Table 1: Demographic Characteristic 
CHARACTERISTIC 
CERVICAL CANCER (n=41) 
BREAST CANCER 
(n=26) 
FREQUENCY % FREQUENCY % 
1.    Age (years old)     
a. 21-30 0 0 1 3.85 
b. 31-40 
c. 41-50 
d. 51-60 
e. 61-70 
f. > 70 
4 
8 
15 
13 
1 
9.76 
19.51 
36.59 
31.71 
2.44 
8 
6 
5 
4 
2 
30.77 
23.08 
19.23 
15.38 
7.69 
2.    Religion 
a.   Catholic 
b.   Christian 
c.   Islam 
 
0 
7 
34 
 
0 
17.07 
82.93 
 
1 
5 
20 
 
3.85 
19.23 
76.92 
3.    Ethnic 
a.   Javanese 
b.   Maduranese 
c.   Chinese 
 
34 
6 
1 
 
82.93 
14.63 
2.44 
 
25 
0 
1 
 
96.15 
0 
3.85 
4.   Educational background 
a. Primary school 
 
15 
 
36.59 
 
5 
 
19.23 
b. Secondary school 
c. High school 
d. Diploma / Bachelor degree 
e. Uneducated 
12 
9 
2 
3 
29.27 
21.95 
4.88 
7.32 
1 
13 
7 
0 
3.85 
50.00 
26.92 
0 
5.    Marital status 
a.   Single 
b.   Married 
c.   Widow 
 
2 
35 
4 
 
4.88 
85.37 
9.76 
 
3 
18 
5 
 
11.54 
69.23 
19.23 
6.   Living at home with 
a.  Spouse 
b.  Children 
c.  Alone 
d.  Parents 
e.  Sibling 
7.    Occupational status 
a.   Full-timer 
b.   Part-timer 
c.   Retired 
d.   Housewife 
e.   Unemployed 
 
35 
16 
2 
0 
0 
 
2 
3 
0 
34 
2 
 
85.37 
39.02 
4.88 
0 
0 
 
4.88 
7.32 
0 
82.93 
4.88 
 
14 
17 
0 
4 
1 
 
4 
2 
4 
16 
0 
 
53.85 
65.38 
0 
15.38 
3.85 
 
15.38 
7.69 
15.38 
61.54 
0 
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8.    GDP per month 
a.   Less than minimum wage 
b.   Minimum wage – IDR 5 million 
c.   More than IDR 5 million 
d.   No income 
 
31 
5 
3 
2 
 
75.61 
12.20 
7.32 
4.88 
 
11 
6 
5 
4 
 
42.31 
23.08 
19.23 
15.38 
 
 
 
 
Table 2: Primary Data 
CHARACTERISTIC 
CERVICAL CANCER 
(n=41) 
BREAST CANCER  
(n=26)  
FREQUENCY % FREQUENCY % 
1.    Firstly diagnosed 
       a.   2018 
       b.   2017 
       c.   2016 
       d.   2015 
       e.   2014 
       f.    < 2014 
 
0 
5 
10 
5 
5 
16 
 
0 
12.20 
24.39 
12.20 
12.20 
39.02 
 
1 
7 
4 
4 
2 
8 
 
3.85 
26.92 
15.38 
15.38 
7.69 
30.77 
2.    Type of therapy 
       a.   Chemotherapy 
       b.   Surgery + chemotherapy        
       c.   Chemotherapy + radiotherapy 
       d.   Surgery + chemotherapy + radiotherapy 
       e.   Surgery + chemotherapy + radiotherapy + 
analgesic  
       f.   Surgery + chemotherapy + radiotherapy + 
medicine 
 
13 
2 
7 
17 
1 
1 
 
31.71 
4.88 
17.07 
41.46 
2.44 
2.44 
 
9 
11 
1 
5 
0 
0 
 
34.62 
42.31 
3.85 
19.23 
0 
0 
 
Table 3: CRF Level 
CHARACTERISTIC 
CERVICAL CANCER (n=41) BREAST CANCER  
(n=26)  
FREQUENCY % FREQUENCY % 
1. Mild 31 75.61 12 46.15 
2. Moderate 9 21.95 11 42.31 
3. Severe 1 2.44 3 11.54 
 
Although therapy has no significant effect on CRF, 
but we could see from Table 2 that most breast cancer 
survivors undertook surgery plus chemotherapy 
regiments, while cervical cancer survivors undertook 
that regiments also but plus radiotherapy (more 
complex). The complexity of therapy was determined 
by cancer progression, individual condition, 
preferences/perception, and other subjective factors 
involve both physicians and the patients. CRF is one of 
the most common symptoms reported by patients and 
is defined as the feeling of extraordinary exhaustion 
associated with a high level of distress, 
disproportionate to the patients’ activity, and is not 
relieved by sleep or rest [25]. Prevalence rates range 
from 59 to nearly 100% depending on the clinical 
status of the cancer. At present, the etiology of CRF is 
poorly understood and the relative contributions of the 
neoplastic disease, various forms of cancer therapy, 
and comorbid conditions remain unclear. In any 
individual, the etiology of CRF probably involves the 
dysregulation of several physiological and 
biochemical systems. Mechanisms proposed as 
underlying CRF include 5-HT neurotransmitter 
dysregulation, vagal afferent activation, alterations in 
muscle and ATP metabolism, HPA axis disfunction 
(hypothalamic–pituitary–adrenal pathway), circadian 
rhythm disruption, and cytokine dysregulation. 
Currently, these mechanisms are largely based on 
evidence from other conditions in which fatigue is a 
characteristic, in particular chronic fatigue syndrome 
and exercise-induced fatigue [16]. 
Borneman (2013) proposed some factors that 
potentially influence CRF other than therapy, such as 
cancer symptoms (physically and psychologically), 
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comorbidity in various body systems, and infection 
[4]. Physical cancer symptoms which could induce 
CRF e.g. pain, shortness of breath, inability to perform 
daily tasks, palpitations, insomnia, lack of appetite, 
and immobility; while the psychological symptoms 
include depressed mood, anxiety, and emotional 
distress. Borneman statements was confirmed in the 
previous study of Minton, et al. (2012) towards 105 
breast cancer survivors with CRF by results of there 
was a significant correlation found between pain, 
insomnia, anxiety, and depression with CRF [13]. 
Comorbidity refers to not only organ function failure 
which includes cardio, renal, pulmo, nerve, digestive, 
liver, and endocrine [4]; but also anemia, cachexia, 
sleep disorders, and depression [16]. Increased risk of 
infection in cancer patients could happen because of 
poor protein and caloric intake post-chemotherapy 
due to its side effects of nausea and vomiting resulted 
in low immunity [12, 21]. In cancer patients, nutrients 
can affect tumor biology, comorbidity and therapeutic 
response [1]. Weight loss and nutritional problems are 
often associated with cancer [18]. Cancer in the body 
and therapy undertaken by cancer patients make 
nutrition problems worsen [7, 20]. CRF is an 
important symptom in cancer and has been shown to 
be associated with psychological and emotional 
distress [3, 5]. Low immunity related to increase risk 
of infection in cancer patients could be a result of 
psychological distress also. Depression, anxiety, and 
stress are associated with cancer. Stress, anxiety, and 
depression have been found to depress the immune 
system. Depression and stress have also been found to 
create inflammatory changes in the body and there is 
emerging evidence that inflammation is involved in 
cancer pathogenesis and in CRF [24]. CRF in breast 
cancer was significantly different from CRF in 
cervical cancer in this study context. We could find 
more mild to moderate CRF in breast cancer compare 
to most mild CRF in cervical cancer respondents 
(Table 3). After deeper analysis using independent T 
test, it was found that those significant differences 
caused by CRF-induced mood disorder and CRF 
occurrence per day. Most respondents of breast cancer 
experienced mild mood disorder (50%) and low 
occurrence of CRF per day (61.54%), while most 
respondents of cervical cancer experienced mild mood 
disorder (75.61%) and low occurrence of CRF per day 
(85.37%). Mood is a person’s subjective emotional 
state. According to the DSM-IV the term mood 
disorder is used for a group of diagnoses where the 
primary symptom is a disturbance in mood, or in other 
words the experience of an inappropriate, exaggerated 
or limited range of feelings. Mood disorders are 
common in patients with cancer which probably cause 
by an imbalance in neurotransmitters [8]. CRF 
syndrome in disease free breast cancer survivors has a 
significant effect on mood disorder [2]. The mood 
disorder can be triggered by the cancer diagnosis on its 
own, or it can be treatment-induced in cases where the 
aetiology can be found in the physiological effect of a 
psychoactive drug or chemical substance [8]. A study 
towards 60 breast cancer survivors with CRF compare 
to 140 breast cancer survivors without CRF showed 
that there was a significant difference of mood found 
[2]. Similar study in cervical cancer survivors is not 
found yet, therefore this condition gives a big chance 
for upcoming studies in this area. Several common 
problems are associated with CRF in women with 
breast cancer, including treatment side effects, 
obesity, arm/upper quadrant symptoms, sleep 
disturbances, psychological effects, and comorbid 
conditions [3]. CRF in cervical and breast cancer 
survivors could be perceived in many different 
perspectives by the individuals. FSI used in this study 
enable cancer survivors to make independent 
self-assessment about their CRF condition. CRF 
assessment in cancer patients needs to be done 
continuously to support early diagnosis and treatment 
of CRF, so that optimum quality of life could be 
assured. This study has some limitations also.  The 
nature of cross-sectional study with a single time point 
data collection has made the pattern, consistency, and 
intensity of CRF value over time was not assessed. 
Future study needs to incorporate a longitudinal 
cohort design to improve the present research 
methodology. Other than study design, weakness also 
presents in the instrument. FSI does not consider 
subjective value, such as culture, habit, and other 
individual background, but being used to assess 
something subjective like CRF. There is a possibility 
that the judgements of respondents influenced by not 
only physical condition related to cancer and its 
treatment, but also specific individual value or 
preferences.    
 
CONCLUSION 
 
There was a significant difference of CRF between 
cervical and breast cancer survivors, especially the 
aspects of CRF-induced mood disorder and the 
frequency of CRF occurrence per day. Regiments of 
cervical and breast cancer was not significantly 
different. Chemotherapy has no significant effect on 
CRF in cervical and breast cancer survivors. Other 
potential factors possibly play a more important role in 
determining CRF level in both cases, such as cancer 
symptom, malnutrition, infection, comorbidity, 
psychological and emotional distress. 
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